Observations on some pharmacologic properties of a new ester of the nicotinic acid: mesoinositol-pentanicotinate.
D000284:Administration, Oral; D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002784:Cholesterol / Q000097:blood*; D004036:Diet, Atherogenic; D004305:Dose-Response Relationship, Drug; D004952:Esters / Q000494:pharmacology; D005260:Female; D005263:Femoral Artery / Q000187:drug effects; D005342:Fibrinolysis / Q000187:drug effects; D006937:Hypercholesterolemia / Q000188:drug therapy; D007294:Inositol / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D008055:Lipids / Q000097:blood*; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats; D014665:Vasodilator Agents / Q000494:pharmacology
D000924:Anticholesteremic Agents; D004952:Esters; D008055:Lipids; D009539:Nicotinic Acids; D014665:Vasodilator Agents; D007294:Inositol; D002784:Cholesterol